Clinical Trial Update: In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial [Phase 1, Phase 2]

View source ↗

Summary

The INVITE trial is investigating in-home intravesical chemotherapy for non-muscle invasive bladder cancer and is currently recruiting for Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma in Situ of the Bladder
• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING